BRIVIACT 10 mg/ml, oral solution bottle
Active ingredients: BRIVARACÉTAM
Commercialized according to BDPMDispensing in France: Prescription only
Oral solutionbottleorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BRIVIACT 10 mg/ml, solution buvable
- Pharmaceutical form
- solution buvable
- Route of administration
- orale
- Presentation description
- flacon(s) en verre jaune(brun) avec fermeture de sécurité enfant avec seringue(s) pour administration orale avec adaptateur
- Marketing authorisation holder
- UCB PHARMA BELGIQUE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 26 Feb 2020
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67429003CIP73005368CIP133400930053683Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BRIVARACÉTAMsolution | 10 mg · 1 ml de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.